MDxHealth Reports Strong 2025 Revenue Growth, Positive 2026 Guidance, and Amends Earnout Terms to Boost Liquidity
MDXH has more than doubled off its 52-week low of $1.35.
Summary
MDxHealth reported strong preliminary 2025 revenues and issued robust 2026 guidance, alongside amending earnout terms with Exact Sciences to defer significant payments in exchange for warrant issuance.
Key Events · Financing and Capital Events · MDXH
-
Strong Preliminary 2025 Revenues
The company expects to report approximately $109 million in revenue for the full year 2025, representing 21% year-over-year growth.
-
Positive 2026 Revenue Guidance
MDxHealth issued 2026 revenue guidance of $137-140 million, indicating robust year-over-year growth of 26-28%.
-
Earnout Payment Deferral
An amendment with Exact Sciences defers $54.5 million in earnout obligations over 2026-2028, significantly improving the company's near-term liquidity.
-
Warrant Issuance
In consideration for the deferral, MDxHealth agreed to issue 3 million warrants to Exact Sciences, exercisable at $5.265 per share, representing potential future dilution.
Analysis · MDXH · Industrial Applications And Services
MDxHealth's strong preliminary 2025 revenue growth and robust 2026 guidance signal continued operational momentum and market penetration. The amendment to the earnout terms with Exact Sciences is a critical financial development, significantly enhancing the company's near-term liquidity by deferring over $50 million in obligations. While the issuance of warrants introduces potential future dilution, the exercise price is at a premium to the current stock price, and the immediate cash flow benefit from the deferral is highly beneficial for the company's financial stability and ability to fund its growth strategy. Investors should view the improved financial flexibility and sustained growth trajectory positively.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDXH was trading at $3.27 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $161.9M. The 52-week trading range was $1.35 to $5.33. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.